Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Novavax, Inc. (NVAX) to Present at the ROTH Capital Partners 24th Annual Conference

Novavax is a global clinical-stage biopharmaceutical company engaged in creating novel vaccines to address a wide range of infectious diseases throughout the world. Using innovative technology and new efficient manufacturing approaches, Novavax produces potent vaccine candidates with the goal of enabling countries to be well-prepared for and more effectively responsive to rapidly spreading infections. Committed to using its technology platforms to create location-specific vaccine solutions, Novavax is involved in a number of international partnerships. For more information visit www.novavax.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below:

This year's annual ROTH Conference will take place at The Ritz Carlton located in Laguna Niguel, on March 17-12, 2013. Bringing together executives from more than 400 growth companies, the ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com.
This entry was posted in ROTH Capital Partners Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *